Pediatric drug safety surveillance in Italian pharmacovigilance network: An overview of adverse drug reactions in the years 2001-2012

Expert Opinion on Drug Safety

Volumn 13, Issue SUPPL. 1, 2014, Pages

  Ferrajolo, Carmen ^a,b   Capuano, Annalisa ^a   Trifirò, Gianluca ^b,c   Moretti, Ugo ^d   Rossi, Francesco ^a   Santuccio, Carmela ^e  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e ITALIAN MEDICINES AGENCY   (Italy)

Author keywords

Adverse drug reaction; Children; Pharmacovigilance; Spontaneous reporting system

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFIXIME; CEFTRIAXONE; CLARITHROMYCIN; CYTARABINE; DECONGESTIVE AGENT; DOMPERIDONE; IBUPROFEN; IMMUNOMODULATING AGENT; KETOPROFEN; METHOTREXATE; METOCLOPRAMIDE; MONTELUKAST; NEUROLEPTIC AGENT; NIFLUMIC ACID; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; UNINDEXED DRUG; VINCRISTINE;

ADOLESCENT; ADVERSE DRUG REACTION; ANAPHYLACTIC SHOCK; ATAXIA; BRADYCARDIA; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILD HOSPITALIZATION; CONVULSION; DISEASE SEVERITY; DROWSINESS; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DYSPNEA; ERYTHEMA; EXTRAPYRAMIDAL SYNDROME; FEMALE; GASTROINTESTINAL DISEASE; HOSPITAL PHYSICIAN; HUMAN; IMMUNOPATHOLOGY; INFANT; ITALY; LETHARGY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM DISEASE; MENTAL DISEASE; NEUROLOGIC DISEASE; NEWBORN; PEDIATRICIAN; PERIPHERAL NEUROPATHY; PHARMACIST; POSTMARKETING SURVEILLANCE; PRESCRIPTION; RESPIRATORY TRACT DISEASE; REVIEW; SKIN ALLERGY; SKIN DISEASE; SKIN MANIFESTATION; THORAX DISEASE; UNSPECIFIED SIDE EFFECT; VOLUNTARY REPORTING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FACTUAL DATABASE; PRESCHOOL CHILD; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MALE; PHARMACOVIGILANCE; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 84907027910     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2014.939581     Document Type: Review

References (44)

1. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 2000;320(7227):79-82
2. Dunne J. The European Regulation on medicines for paediatric use. Paediatr Respir Rev 2007;8(2):177-83
3. Noren GN, Hopstadius J, Bate A. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res 2013;22(1):57-69
4. Ryan PB, Madigan D, Stang PE, et al. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat Med 2012;31(30):4401-15
5. Coloma PM, Avillach P, Salvo F, et al. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases. Drug Saf 2013;36(1):13-23
6. Trifiro G, Pariente A, Coloma PM, et al. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor Pharmacoepidemiol Drug Saf 2009;18(12):1176-84
7. Ferrajolo C, Coloma PM, Verhamme KM, et al. Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network. Drug Saf 2014;37(2):99-108
8. Ferrajolo C, Verhamme KM, Trifiro G, et al. Idiopathic acute liver injury in paediatric outpatients: incidence and signal detection in two european countries. Drug Saf 2013;36(10):1007-16
9. Star K. Detecting unexpected adverse drug reactions in children. Paediatr Drugs 2011;13(2):71-3
10. Ferrajolo C, Capuano A, Verhamme KM, et al. Drug-induced hepatic injury in children: a case/noncase study of suspected adverse drug reactions in VigiBase. Br J Clin Pharmacol 2010;70(5):721-8.
11. Hammond IW, Gibbs TG, Seifert HA, Rich DS. Database size and power to detect safety signals in pharmacovigilance. Expert Opin Drug Saf 2007;6(6):713-21
12. Aagaard L, Weber CB, Hansen EH. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf 2010;33(4):327-39.
13. Aldea A, Garcia Sanchez-Colomer M, Fernandez Quintana E, Garcia Saiz M. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from. 2004 to 2009. Eur J Clin Pharmacol 2012;68(9):1329-38
14. Capuano A, Irpino A, Gallo M, et al. Regional surveillance of emergencydepartment visits for outpatient adverse drug events. Eur J Clin Pharmacol 2009;65(7):721-8.
15. Hawcutt DB, Mainie P, Riordan A, et al. Reported paediatric adverse drug reactions in the UK 2000-2009. Br J Clin Pharmacol 2012;73(3):437-46.
16. Morales-Olivas FJ, Martinez-Mir I, Ferrer JM, et al. Adverse drug reactions in children reported by means of the yellow card in Spain. J Clin Epidemiol 2000;53(10):1076-80.
17. Star K, Noren GN, Nordin K, Edwards IR. Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase. Drug Saf 2011;34(5):415-28
18. Wallerstedt SM, Brunlof G, Sundstrom A. Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a crosssectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register. Drug Saf 2011;34(8):669-82.
19. AIFA. Available from: http://www. agenziafarmaco.gov.it/en/content/ postmarketing-surveillance [Last Access date 10 April 2014]
20. Pugi A, Bonaiuti R, Maggini V, et al. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database. Am J Health Syst Pharm 2013;70(12):1039-46
21. Leone R, Moretti U, D'Incau P, et al. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study. Drug Saf 2013;36(4):267-76
22. Conforti A, Opri S, D'Incau P, et al. Adverse drug reaction reporting by nurses: analysis of Italian pharmacovigilance database. Pharmacoepidemiol Drug Saf 2012;21(6):597-602
23. Parretta E, Ianniello B, Ferrazin F, et al. Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination. Vaccine 2011;29(20):3708-13
24. Mazzitello C, Esposito S, De Francesco AE, et al. Pharmacovigilance in Italy: an overview. J Pharmacol Pharmacother 2013;4(Suppl 1):S20-8
25. Pimpinella G, Tartaglia L. Pharmacovigilance and the italian medicines agency. J Pharmacol Pharmacother 2013;4(Suppl 1):S4-6
26. Meyboom RH. Adverse reaction to drugs in children, experiences with "spontaneous monitoring" in the Netherlands. Bratisl Lek Listy 1991;92(11):554-9
27. Subbarao P, Mandhane PJ, Sears MR. Asthma: epidemiology, etiology and risk factors. CMAJ 2009;181(9):E181-90
28. Tekgul S, Riedmiller H, Hoebeke P, et al. EAU guidelines on vesicoureteral reflux in children. Eur Urol 2012;62(3):534-42
29. Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007;164(6):942-8
30. Sturkenboom MC, Verhamme KM, Nicolosi A, et al. Drug use in children: cohort study in three European countries. BMJ 2008;337:a2245
31. Walsh KE, Mazor KM, Stille CJ, et al. Medication errors in the homes of children with chronic conditions. Arch Dis Child 2011;96(6):581-6
32. Ozdemir R, Bayrakci B, Teksam O, et al. Thirty-three-year experience on childhood poisoning. Turk J Pediatr 2012;54(3):251-9
33. Fluhr JW, Pfisterer S, Gloor M. Direct comparison of skin physiology in children and adults with bioengineering methods. Pediatr Dermatol 2000;17(6):436-9
34. Gruchalla RS, Pirmohamed M. Clinical practice. Antibiotic allergy. N Engl J Med 2006;354(6):601-9
35. Traversa G, Capuano A, Da Cas R, et al. Neurological disorders associated with vaccine use: a prospective case-control study. Drug Saf 2004;27(12):963-4
36. EMA. European medicines agency recommends changes to the use of metoclopramide. Available from: http://www.ema.europa.eu/docs/en-GB/document- library/Referrals-document/Metoclopramide-31/WC500146610.pdf [Last Access date 10 April 2014]
37. Bate A, Lindquist M, Edwards IR. The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database. Fundam Clin Pharmacol 2008;22(2):127-40
38. Mittmann N, Knowles SR, Gomez M, et al. Evaluation of the extent of underreporting of serious adverse drug reactions: the case of toxic epidermal necrolysis. Drug Saf 2004;27(7):477-87
39. Bertuola F, Morando C, Menniti-Ippolito F, et al. Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy. Drug Saf 2010;33(1):65-72
40. Capuano A, Motola G, Russo F, et al. Adverse drug events in two emergency departments in Naples, Italy: an observational study. Pharmacol Res 2004;50(6):631-6
41. Rafaniello C, Lombardo F, Ferrajolo C, et al. Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy. Eur J Clin Pharmacol 2014;70(2):187-95
42. Guideline on conduct of pharmacovigilance for medicines used by the paediatric population. Available from: http://www.ema.europa.eu/docs/en-GB/ document-library/Scientific-guideline/2009/09/WC500003764.pdf [Last Access date 25 January 2007]
43. Farmaco AId. Ceftriaxone e shock anafilattico. Available from: http://www. agenziafarmaco.gov.it/sites/default/files/ceftriaxone-e-shock- anafilattico-ok.pdf [Last Access date 10 April 2014]
44. Farmaco AId. TINSET 2.5% gocce orali sospensione (oxatomide). Available from: http://www.agenziafarmaco.gov.it/sites/default/files/nii-final-cts- settembre-10-0.pdf [Last Access date 14 April 2014]